International Biotechnology Trust as of June 30, 2021
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 66 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 7.4 | $28M | 403k | 68.83 | |
Alnylam Pharmaceuticals (ALNY) | 6.7 | $25M | 149k | 169.39 | |
Seagen | 6.1 | $23M | 145k | 157.71 | |
Horizon Therapeutics Pub SHS | 5.9 | $22M | 238k | 93.64 | |
Regeneron Pharmaceuticals (REGN) | 5.5 | $21M | 37k | 558.55 | |
Neurocrine Biosciences (NBIX) | 5.4 | $20M | 207k | 97.23 | |
Ptc Therapeutics I (PTCT) | 5.0 | $19M | 449k | 42.20 | |
Biohaven Pharmaceutical Holding | 4.6 | $17M | 176k | 97.01 | |
Biogen Idec (BIIB) | 4.5 | $17M | 49k | 346.27 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $13M | 65k | 201.61 | |
Amgen (AMGN) | 3.3 | $12M | 51k | 243.75 | |
Incyte Corporation (INCY) | 3.1 | $12M | 137k | 84.09 | |
Uniqure Nv SHS (QURE) | 2.6 | $9.7M | 316k | 30.76 | |
Turning Point Therapeutics I | 2.5 | $9.5M | 122k | 78.01 | |
United Therapeutics Corporation (UTHR) | 2.1 | $7.8M | 43k | 179.40 | |
Acceleron Pharma | 2.0 | $7.6M | 61k | 125.49 | |
Ionis Pharmaceuticals (IONS) | 1.9 | $7.3M | 182k | 39.89 | |
Protagonist Therapeutics (PTGX) | 1.8 | $6.8M | 152k | 44.82 | |
Kalvista Pharmaceuticals (KALV) | 1.8 | $6.8M | 283k | 23.96 | |
Supernus Pharmaceuticals (SUPN) | 1.7 | $6.2M | 202k | 30.79 | |
Ultragenyx Pharmaceutical (RARE) | 1.5 | $5.7M | 60k | 95.36 | |
Harmony Biosciences Hldgs In (HRMY) | 1.2 | $4.7M | 166k | 28.23 | |
BioMarin Pharmaceutical (BMRN) | 1.2 | $4.6M | 55k | 83.44 | |
Aurinia Pharmaceuticals (AUPH) | 1.0 | $3.9M | 299k | 12.96 | |
Halozyme Therapeutics (HALO) | 1.0 | $3.8M | 83k | 45.41 | |
Deciphera Pharmaceuticals | 1.0 | $3.7M | 100k | 36.61 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.9 | $3.6M | 20k | 177.65 | |
Intra Cellular Therapies (ITCI) | 0.9 | $3.2M | 80k | 40.81 | |
Insmed (INSM) | 0.8 | $2.8M | 100k | 28.46 | |
Dyne Therapeutics (DYN) | 0.8 | $2.8M | 135k | 21.04 | |
Mirati Therapeutics | 0.7 | $2.7M | 17k | 161.54 | |
Hutchmed China Sponsored Ads (HCM) | 0.7 | $2.7M | 68k | 39.28 | |
Sutro Biopharma (STRO) | 0.7 | $2.6M | 139k | 18.59 | |
Sarepta Therapeutics (SRPT) | 0.7 | $2.5M | 32k | 77.78 | |
Chinook Therapeutics | 0.6 | $2.4M | 171k | 14.12 | |
Zai Lab Adr (ZLAB) | 0.6 | $2.3M | 13k | 176.88 | |
Nkarta (NKTX) | 0.6 | $2.2M | 70k | 31.63 | |
Guardant Health (GH) | 0.6 | $2.1M | 17k | 124.24 | |
Exelixis (EXEL) | 0.5 | $1.9M | 102k | 18.22 | |
Ascendis Pharma AS Sponsored ADR (ASND) | 0.5 | $1.8M | 14k | 131.52 | |
Blueprint Medicines (BPMC) | 0.5 | $1.7M | 20k | 87.95 | |
Iovance Biotherapeutics (IOVA) | 0.4 | $1.5M | 58k | 26.02 | |
Enanta Pharmaceuticals (ENTA) | 0.4 | $1.5M | 34k | 44.00 | |
Apellis Pharmaceuticals CM (APLS) | 0.4 | $1.5M | 23k | 63.08 | |
Arena Pharmaceuticals Com New | 0.4 | $1.4M | 21k | 68.14 | |
Allakos (ALLK) | 0.4 | $1.3M | 16k | 85.22 | |
EXACT Sciences Corporation (EXAS) | 0.4 | $1.3M | 11k | 124.11 | |
Agios Pharmaceuticals (AGIO) | 0.3 | $1.2M | 22k | 55.12 | |
Nektar Therapeutics (NKTR) | 0.3 | $1.1M | 67k | 17.15 | |
Alkermes SHS (ALKS) | 0.3 | $1.1M | 45k | 24.51 | |
Axsome Therapeutics (AXSM) | 0.3 | $944k | 14k | 67.43 | |
Oric Pharmaceuticals (ORIC) | 0.2 | $938k | 53k | 17.70 | |
Amicus Therapeutics (FOLD) | 0.2 | $912k | 95k | 9.64 | |
Chemocentryx | 0.2 | $777k | 58k | 13.38 | |
Global Blood Therapeutics In | 0.2 | $763k | 22k | 35.00 | |
Gamida Cell SHS | 0.2 | $682k | 107k | 6.37 | |
Immunovant (IMVT) | 0.2 | $634k | 60k | 10.57 | |
Ardelyx (ARDX) | 0.2 | $591k | 78k | 7.58 | |
Black Diamond Therapeutics (BDTX) | 0.1 | $535k | 44k | 12.16 | |
Fibrogen (FGEN) | 0.1 | $525k | 20k | 26.65 | |
I Mab Sponsored Ads (IMAB) | 0.1 | $503k | 6.0k | 83.83 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $474k | 26k | 18.59 | |
Bluebird Bio (BLUE) | 0.1 | $351k | 11k | 31.91 | |
Travere Therapeutics (TVTX) | 0.1 | $292k | 20k | 14.60 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $259k | 10k | 25.90 | |
Esperion Therapeutics (ESPR) | 0.1 | $201k | 9.5k | 21.16 |